이상반응 보고
| VAERS ID | 1786406 |
|---|---|
| 성별 | 여성 |
| 나이 | 32세 |
| 주 코드 | FR |
| 제약회사 | MODERNA |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-29 |
| 발병일 | 2021-09-30 |
| 상태 |
증상
- 피로(Fatigue)
- 발열(Pyrexia)
- 두통(Headache)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
Pregnancy
지병
기타 의료
FOLIC ACID
이전 예방접종
알레르기
임상 검사
증상 상세
Maternal exposure during pregnancy; Fever; Headache; Fatigue; This case was received via the RA (Reference number: GB-MHRA-ADR 26046930) on 07-Oct-2021 and was forwarded to Moderna on 07-Oct-2021.
This regulatory authority prospective pregnancy case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Headache), FATIGUE (Fatigue) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna CoviD-19 Vaccine) for COVID-19 vaccination.
Concurrent medical conditions included Pregnancy.
Concomitant products included FOLIC ACID for Folic acid supplementation.
On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) 1 dosage form.
On 30-Sep-2021, received second dose of mRNA-1273 (Moderna CoviD-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.
Last menstrual period and estimated date of delivery were not provided.
On 30-Sep-2021, the patient experienced PYREXIA (Fever) (seriousness criterion medically significant), HEADACHE (Headache) (seriousness criterion medically significant) and FATIGUE (Fatigue) (seriousness criterion medically significant).
On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) (seriousness criterion medically significant).
At the time of the report, PYREXIA (Fever) had not resolved, HEADACHE (Headache) had resolved, FATIGUE (Fatigue) was resolving and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) outcome was unknown.
The action taken with mRNA-1273 (Moderna CoviD-19 Vaccine) (Unknown) was unknown.
Treatment medication were not reported.
Patient has not had symptoms associated with COVID-19, not had a COVID-19 test Patient is not currently breastfeeding Patient not tested positive for COVID-19 since had the vaccine Patient was not enrolled in clinical trial Patient was exposed to the medicine first-trimester (1-12 weeks).
This case concerns a 32-year-old, female pregnant patient with no relevant medical history, who experienced the unexpected events of maternal exposure during pregnancy, pyrexia, headache and fatigue.
Last menstrual period of the patient and estimated date of delivery were not provided.
The events were experienced the same day the patient received the second dose of Moderna Covid-19 vaccine.
The benefit-risk relationship of the vaccine is not affected by this report.
; Sender's Comments: This case concerns a 32-year-old, female pregnant patient with no relevant medical history, who experienced the unexpected events of maternal exposure during pregnancy, pyrexia, headache and fatigue.
Last menstrual period of the patient and estimated date of delivery were not provided.
The events were experienced the same day the patient received the second dose of Moderna Covid-19 vaccine.
The benefit-risk relationship of the vaccine is not affected by this report.